• Introduction
• Outcomes for Withdrawal
• Outcomes for Maintenance Treatment
• Outcomes from the National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) Project
• Process Issues
• Implementation Guidelines
• Conclusion

Richard P. Mattick, University of New South Wales, Sydney, (Australia)

Director of Research, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. He is Executive Editor of Drug and Alcohol Review and Assistant Editor of Addiction (previously British Journal of Addiction).

Robert Ali, University of Adelaide, Adelaide, (Australia)

Head of World Health Organization Collaborating Centre for Research and Treatment of Drug and Alcohol Problems, and Director, Clinical Services and Research, Drug and Alcohol Services South Australia, Australia. He is a Fellow of the Australasian Chapter of Addiction Medicine in the Royal Australasian College of Physicians. Dr. Ali is a member of the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems and is Project coordinator for two World Health Organisation projects. He is also a member of the Cochrane Alcohol and Drug Group editorial board.

Nicholas Lintzeris, University of Sidney, Sidney, (Australia)

Honorary Senior Lecturer at the National Addiction Centre, Institute of Psychiatry, and a locum Consultant in Addiction Medicine at the South London and Maudsley Trust, London, UK. He is also a Foundation Fellow of the Australasian Chapter of Addiction Medicine. Dr. Lintzeris is a principle investigator of the impending “Randomised controlled trial of injectable opioid treatment.”